« Home « Kết quả tìm kiếm

Bleeding and Thrombosis


Tìm thấy 11+ kết quả cho từ khóa "Bleeding and Thrombosis"

Chapter 059. Bleeding and Thrombosis (Part 4)

tailieu.vn

Bleeding and Thrombosis (Part 4). Approach to the Patient: Bleeding and Thrombosis. Disorders of hemostasis may be either inherited or acquired. A detailed personal and family history is key in determining the chronicity of symptoms and the likelihood of the disorder being inherited and it provides clues to underlying conditions that have contributed to the bleeding or thrombotic state.

Chapter 059. Bleeding and Thrombosis (Part 1)

tailieu.vn

Bleeding and Thrombosis (Part 1). Bleeding and Thrombosis. Bleeding and Thrombosis: Introduction. The human hemostatic system provides a natural balance between procoagulant and anticoagulant forces. The procoagulant forces include platelet adhesion and aggregation and fibrin clot formation. anticoagulant forces include the natural inhibitors of coagulation and fibrinolysis..

Chapter 059. Bleeding and Thrombosis (Part 7)

tailieu.vn

Venous thrombosis: A multicausal disease. Careful history taking and clinical examination are essential components in the assessment of bleeding and thrombotic risk. The use of laboratory tests of coagulation complement, but cannot substitute for, clinical assessment. No test provides a global assessment of hemostasis. The bleeding time has been used to assess bleeding risk. however, it does not predict bleeding risk with surgery and is not recommended for this indication.

Chapter 059. Bleeding and Thrombosis (Part 6)

tailieu.vn

The major risk factor for arterial thrombosis is atherosclerosis, while those for venous thrombosis are immobility, surgery, underlying medical conditions such as malignancy, medications such as hormonal therapy, obesity, and genetic predispositions. Factors that increase risks for venous and both venous and arterial thromboses are shown in Table 59-3.. Table 59-3 Risk Factors for Thrombosis. Venous Venous and Arterial. Protein C deficiency Mixed (Inherited and acquired).

Chapter 059. Bleeding and Thrombosis (Part 9)

tailieu.vn

Standard curves are created using multiple concentrations of UFH and LMWH and are used to calculate the concentration of anti-Xa activity in the patient plasma.. Antithrombin is decreased by heparin and in the setting of acute thrombosis. Protein C and S levels may be increased in the setting of acute thrombosis and are decreased by warfarin..

Chapter 059. Bleeding and Thrombosis (Part 5)

tailieu.vn

It is uncommon in children with mild bleeding disorders. Menorrhagia is a common symptom in women with underlying bleeding disorders and is reported in the majority of women with vWD and factor XI deficiency and in symptomatic carriers of hemophilia A. Postpartum hemorrhage is a common symptom in women with underlying bleeding disorders. Rupture of ovarian cysts with intraabdominal hemorrhage has also been reported in women with underlying bleeding disorders..

Chapter 059. Bleeding and Thrombosis (Part 8)

tailieu.vn

Variable, but usually mild, bleeding –factor XI, mild FVIII and FIX. Frequent, severe bleeding – severe deficiencies of FVIII and FIX. Vitamin K deficiency – early. Vitamin K deficiency – late. Direct thrombin inhibitors. Heparin or heparin-like inhibitors. Mild or no bleeding – dysfibrinogenemia. Frequent, severe bleeding – afibrinogenemia. Prolonged PT and/or aPTT not correct with mixing with normal plasma. Bleeding – specific factor inhibitor.

Chapter 059. Bleeding and Thrombosis (Part 3)

tailieu.vn

D-Dimer assays can be used as sensitive markers of blood clot formation, and some have been validated for clinical use to exclude the diagnosis of deep venous thrombosis (DVT) and pulmonary embolism in selected populations.. Physiologic regulation of fibrinolysis occurs primarily at two levels: (1) plasminogen activator inhibitors (PAIs), specifically PAI1 and PAI2, inhibit the physiologic plasminogen activators.

Association between viscoelastic testsguided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: A before-after study

tailieu.vn

Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. Hemostasis in liver transplantation:. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation:.

Chapter 059. Bleeding and Thrombosis (Part 2)

tailieu.vn

Coagulation is initiated by tissue factor (TF) exposure, which, with. factor (F)VIIa, activates FIX and FX, which in turn, with FVIII and FV as cofactors, respectively, results in thrombin formation and subsequent conversion of fibrinogen to fibrin. Thrombin activates FXI, FVIII, and FV, amplifying the coagulation signal.

Chapter 110. Coagulation Disorders (Part 8)

tailieu.vn

Interestingly, in patients with APL, a severe hyperfibrinolytic state often occurs in addition to the coagulation activation. central roles in mediating the coagulation defects in DIC and symptoms associated with systemic inflammatory response syndrome.. Interactions between coagulation and fibrinolytic pathways result in bleeding and thrombosis in the microcirculation in patients with DIC..

Prevention of postoperative bleeding after complex pediatric cardiac surgery by early administration of fibrinogen, prothrombin complex and platelets: A prospective observational study

tailieu.vn

Conclusion: In this observational study of children with an increased risk of bleeding after CPB, an early preventive therapy with fibrinogen, prothrombin complex and platelets guided by clinical bleeding evaluation and TEG reduced bleeding and improved TEG and standard coagulation parameters significantly, with no occurrence of thrombosis or need for re-operation..

Chapter 109. Disorders of Platelets and Vessel Wall (Part 4)

tailieu.vn

Drug-induced thrombocytopenia due to heparin differs from that seen with other drugs in two major ways. (1) The thrombocytopenia is not usually severe, with nadir counts rarely <20,000/µL. (2) Heparin-induced thrombocytopenia (HIT) is not associated with bleeding and, in fact, markedly increases the risk of thrombosis. HIT results from antibody formation to a complex of the platelet- specific protein platelet factor 4 (PF4) and heparin.

Low flow extracorporeal CO2 removal in ARDS patients: A prospective short-term crossover pilot study

tailieu.vn

Patient 3 had a nosebleed and was bleeding at the insertion points of the ECCO 2 R catheter and the central venous catheter. Patient 4 was bleeding at the in- sertion point of the ECCO 2 R catheter, had a pharyngeal bleeding and hematuria. Patient 5 was bleeding during insertion of the catheter.

Chapter 111. Venous Thrombosis (Part 5)

tailieu.vn

The decision to continue VKA treatment after 6–12 months requires the balancing of the risks of recurrence and bleeding and should take the patient's preference into account

Chapter 112. Venous Thrombosis (Part 5)

tailieu.vn

The decision to continue VKA treatment after 6–12 months requires the balancing of the risks of recurrence and bleeding and should take the patient's preference into account

Chapter 058. Anemia and Polycythemia (Part 11)

tailieu.vn

The dominant symptoms from increased red cell mass are related to hyperviscosity and thrombosis (both venous and arterial), because the blood viscosity increases logarithmically at hematocrits >55%.. Neurologic symptoms such as vertigo, tinnitus, headache, and visual disturbances may occur.. Patients with polycythemia vera may have aquagenic pruritus and symptoms related to hepatosplenomegaly. Patients may have easy bruising, epistaxis, or bleeding from the gastrointestinal tract.

Chapter 109. Disorders of Platelets and Vessel Wall (Part 5)

tailieu.vn

Mucocutaneous bleeding, such as oral mucosa, gastrointestinal, or heavy menstrual bleeding, may be present. Rarely, life-threatening bleeding, including in the central nervous system, can occur. Wet purpura (blood blisters in the mouth) and retinal hemorrhages may herald life- threatening bleeding.. Laboratory Testing in ITP. Laboratory testing for antibodies (serologic testing) is usually not helpful due to the low sensitivity and specificity of the tests.

Anesthetic management of gigantic pheochromocytoma resection with inferior vena cava and right atrium tumor thrombosis: A case report

tailieu.vn

The image of removed inferior vena cava and right atrium thrombosis after the operation. Fortunately, the patient did not show significantly myocardial ischemia and heart failure in the presence of unstable circulation during the operation.. In this case, the successful anesthetic management is mainly due to the positive circulation regulation. In addition, the ligation of the tumor bleeding by surgeon and anesthetic-induced persistent vasodilation normally induced the sudden hypotension..

Case report: Postpartum cerebral venous thrombosis misdiagnosed as postdural puncture headache

tailieu.vn

Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and Dural sinus thrombosis (ISCVT). Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Cerebral venous thrombosis. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Thrombosis of the cerebral veins and sinuses.